Vanguard Global Advisers »

Telomir Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.5k 6.6k 1.30

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Telomir Pharmaceuticals

Vanguard Group
Vanguard Capital Management
BlackRock
Geode Capital Management
Vanguard Fiduciary Trust
Millennium Management
State Street Corporation
Bank of New York Mellon
Suncoast Equity Management
Northern Trust
XTX Topco
Pensionmark Financial Group
Advisor Group Holdings
Resources Investment Advisors
Praetorian Wealth Management

View all funds holding Telomir Pharmaceuticals